GREY:ATBPF - Post by User
Comment by
Inthepezon Aug 19, 2021 12:10pm
126 Views
Post# 33730702
RE:RE:Otenaproxesul and COVID-19 Data
RE:RE:Otenaproxesul and COVID-19 DataI listened to the AGM meeting and it brought up great info. I’m overall bullish.While there will be a 12month delay for ph3, I’m betting we bounce to the $2.5-3 range by December.
Partnership negotiations will resume after the investigation of the AME is complete (which will take 5 weeks according to Dan and Stauffer).
A good take away was Stauffer and Dan mentioning that H2S provides a protective effect on the liver much like the GI effects. And that the ALT elevation is not a serious issue but is a class issue of the drug. Stauffer hammered home, Te elevation is not a serious event.
They also mentioned their naproxen different from commercial naproxen, more stable not up and down like commercial naproxen - so the stability provides protective effective protection, where most of their work is centered around , they think they are close to a dose level that is effective.
overall bullish. Big F***k you to the FUD fairies esp rarbar99 aka Yukonjizz face